Clinical trials: Cytoreductive Gastrectomy
Metastatic Gastric Cancer, Gastric Cancer
Cytoreductive Gastrectomy After Systemic Therapy Versus Systemic Therapy Alone For Limited Metastasis Gastric Cancer
The results of the current studies to determine the optimal strategy for metastatic gastric cancer remain contrversial worldwide.
- Conditions
- Metastatic Gastric Cancer, Gastric Cancer, Systemic Therapy, Cytoreductive Gastrectomy
- Trial name
- CYGAS-GC (NCT06768463)
- Testing
- Cytoreductive Gastrectomy
- Where
- Vietnam
- Volunteers
- 250 people
- Sponsor
- University Medical Center Ho Chi Minh City (UMC)
Stomach Neoplasm, Peritoneal Carcinomatosis
Gastrectomy + Cytoreductive Surgery + HIPEC for Gastric Cancer With Peritoneal Dissemination.
A randomized controlled two-armed phase III trial for gastric cancer patients with peritoneal dissemination. Randomization between gastrectomy + cytoreductive surgery + HIPEC (experimental arm) and palliative systemic…
- Trial name
- PERISCOPEII (NCT03348150)
- Testing
- Cytoreductive surgery + Gastrecomy, Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
- Where
- Netherlands
- Volunteers
- 102 people
- Sponsor
- The Netherlands Cancer Institute